Averitas Pharma, INC
Drug manufacturers.
Based in NJ
AI Overview
With $580K in lobbying spend across 14 quarterly filings, Averitas Pharma, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2019 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $120K |
| 2022 | $220K |
| 2023 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Averitas Pharma, INC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
Issues related to innovative pain therapies.
Issues related to non-opioid, non-addictive pain treatments.
Issues related to Part B Reimbursement.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.